Rob Monteleone - Thorne HealthTech VP Sales
| THRNDelisted Stock | USD 6.40 0.48 8.11% |
Insider
Rob Monteleone is VP Sales of Thorne HealthTech
| Phone | 929 251 6321 |
| Web | https://www.thorne.com |
Similar Executives
| Showing other executives | INSIDER Age | ||
| Robert Partin | Bellring Brands LLC | 70 | |
| Thomas Erickson | Bellring Brands LLC | 65 | |
| Jennifer Kuperman | Bellring Brands LLC | 47 | |
| Steve Axe | Nomad Foods | N/A | |
| Thomas Erb | Post Holdings | 67 | |
| Akshay Jagdale | Real Good Food | N/A | |
| Jennifer Meyer | Bellring Brands LLC | N/A | |
| Shayn Wallace | John B Sanfilippo | 52 | |
| Trent McCausland | Natures Sunshine Products | N/A | |
| Richard Zhang | Natures Sunshine Products | N/A | |
| Douglas Cornille | Bellring Brands LLC | 51 | |
| Jennifer Meyer | Post Holdings | N/A | |
| Mike McGoohan | Central Garden Pet | N/A | |
| Jon Balousek | Central Garden Pet | 55 | |
| Matthew Shurte | Lancaster Colony | 56 | |
| Shaun Mara | Simply Good Foods | 59 | |
| David Wallis | Simply Good Foods | 61 | |
| Michael CPA | John B Sanfilippo | 48 | |
| Mike McGoohan | Central Garden Pet | N/A | |
| CPA CFA | Nomad Foods | N/A | |
| Harriet Hounsell | Nomad Foods | N/A | |
Thorne HealthTech Leadership Team
Elected by the shareholders, the Thorne HealthTech's board of directors comprises two types of representatives: Thorne HealthTech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Thorne. The board's role is to monitor Thorne HealthTech's management team and ensure that shareholders' interests are well served. Thorne HealthTech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Thorne HealthTech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Wilson, VP Relations | ||
| Scott Hurth, Chief Officer | ||
| Paul Jacobson, CEO CoFounder | ||
| William McCamy, President | ||
| Thomas McKenna, COO Director | ||
| Kim Pearson, G Counsel | ||
| Bryan Conley, Chief Officer | ||
| Nathan Price, Chief Onegevity | ||
| Michelle Crow, Chief Officer | ||
| Rob Monteleone, VP Sales |
Thorne Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Thorne HealthTech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Price To Earning | 100.20 X | |||
| Revenue | 228.73 M | |||
| EBITDA | 10.31 M | |||
| Net Income | 14.93 M | |||
| Cash And Equivalents | 27.81 M | |||
| Cash Per Share | 0.53 X | |||
| Total Debt | 47.03 M | |||
| Debt To Equity | 0.24 % | |||
| Current Ratio | 2.91 X | |||
| Book Value Per Share | 2.46 X |
Pair Trading with Thorne HealthTech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Thorne HealthTech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Thorne HealthTech will appreciate offsetting losses from the drop in the long position's value.Moving together with Thorne Stock
The ability to find closely correlated positions to Thorne HealthTech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Thorne HealthTech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Thorne HealthTech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Thorne HealthTech to buy it.
The correlation of Thorne HealthTech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Thorne HealthTech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Thorne HealthTech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Thorne HealthTech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Thorne Stock
If you are still planning to invest in Thorne HealthTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Thorne HealthTech's history and understand the potential risks before investing.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |